Life Sciences Archives - Page 15 of 17 - Becker's Hospital Review

Cancer drug trial halted after patient death | Intermountain launches biotech co. | 150 top places to work in healthcare | Pfizer leads $123M financing round for biotech co. | Mo. health system cuts leadership roles

March 22, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Cancer drug trial halted after patient death Full story 2. 150 top places to work in healthcare | 2023 Full story 3. Intermountain launches biotech company Full story 4. Mental health care is…

US sues Rite Aid | Pfizer to acquire Seagen for $43B | Penn Med cuts jobs | Calif.'s 1st all-electric life sciences facility lands $310M loan | Top 83 hospitals for patients: Healthgrades

March 15, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. US sues Rite Aid for allegedly filling 'unlawful' opioid prescriptions Full story 2. Penn Medicine eliminates administrative jobs in cost-cutting move Full story 3. Pfizer to acquire Seagen for $43B Full story…

Mark Cuban's 1st step into brand-name drug market | 'We're done': Calif. cuts ties with Walgreens | Moderna may test bird flu, mpox vaccines in 2023 | Life sciences co. taps former Dell, IBM leader for CEO

March 8, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Cuban breaks into brand-name drug market Full story 2. Prime Healthcare hospital under investigation after death of new mother Full story 3. 'We're done': California cuts ties with Walgreens over abortion…

Eli Lilly caps insulin costs | Mark Cuban's pharmacy sees 2 million customers | How 5 drugmakers fared in 2022 | Sequoia acquires biotech co. | Hospital margins aren't seeing relief

March 1, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Eli Lilly caps insulin at $35 a month Full story 2. Hospital margins see no relief to start the year Full story 3. Mark Cuban's pharmacy racks up 2 million customers…

Mark Cuban seeks independent pharmacists | Amazon acquires One Medical for $3.9B | Fujifilm Irvine Scientific sued over recalled embryo culture oil | How AI can speed up drug development | 7 US healthcare billionaires

February 22, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Couple sues Fujifilm Irvine Scientific over recalled embryo culture oil Full story 2. Amazon completes $3.9B acquisition of One Medical Full story 3. Mark Cuban's low-cost pharmacy to partner with independent…

HHS unveils 3 new drug price models | Walmart, drugmakers face eye drop suits | Northwell exec weighs in on NY masking requirements | Va. invests $67M in biotech | 11 cities hit hardest by inflation

February 15, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. HHS unveils 3 new drug price models Full story 2. 11 cities hit hardest by inflation Full story 3. Walmart faces suits over eye drops that allegedly killed 1, blinded 5 Full…

Teva exits PhRMA | CVS, Oak Street strike $10.6B deal | Former Google CEO to serve on federal biotech commission | State of the Union: 10 healthcare notes | Pharmacist among those arrested in $1.5M pill mill case

February 8, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Following AbbVie's steps, Teva leaves PhRMA Full story 2. Biden's State of the Union: 10 healthcare takeaways Full story 3. Pharmacist, 8 others arrested in $1.5M pill mill case Full story 4. Across…

Humira's 1st biosimilar enters market | PHE to end May 11 | Pfizer invests $25M in biotech co. | Nurses asked to give up licenses amid fake degree scheme | $290M life sciences facility gets green light

February 1, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. 1st Humira biosimilar enters market with two prices Full story 2. Biden administration to end COVID-19 public health emergency in May Full story 3. Pfizer invests $25M in biotech company Full story…

Amazon kicks off monthly script service | Kroger's 1st personalized medicine trial | Digital life sciences VC fund launches with $350M | Meet Mark Cuban's 3 PBM partners | 20 systems spending the most on contract labor

January 25, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Amazon rolls out RxPass prescription service for $5 per month Full story 2. 20 health systems with highest contract labor expenses Full story 3. Meet the 3 PBMs partnered with Mark…

Drug researcher gets 3 years in prison for asthma drug study lie | Heparin shortage drags on | Cleveland Clinic expects $200M loss | Biotech investment to bounce back | Top 50 hospitals: Healthgrades

January 18, 2023 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Drug researcher sentenced to 3 years in prison for lying about asthma drug study Full story 2. Healthgrades' 50 top hospitals for 2023 Full story 3. 6 drugmakers are short on…